yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q52691073-043D796E-5E59-435D-B701-111CE8640D85
Q52691073-043D796E-5E59-435D-B701-111CE8640D85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52691073-043D796E-5E59-435D-B701-111CE8640D85
15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes.
P2860
Q52691073-043D796E-5E59-435D-B701-111CE8640D85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52691073-043D796E-5E59-435D-B701-111CE8640D85
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be17a1e31b134897ab224cc5a2c9d12828e0258a
P2860
Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective.